Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
- PMID: 17136094
- DOI: 10.1038/nature05327
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Similar articles
-
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.Nature. 2006 Nov 30;444(7119):633-7. doi: 10.1038/nature05268. Nature. 2006. PMID: 17136093
-
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22. Nat Cell Biol. 2007. PMID: 17450133
-
DNA damage signalling guards against activated oncogenes and tumour progression.Oncogene. 2007 Dec 10;26(56):7773-9. doi: 10.1038/sj.onc.1210881. Oncogene. 2007. PMID: 18066090 Review.
-
Oncogene-induced cellular senescence.Adv Anat Pathol. 2010 Jan;17(1):42-8. doi: 10.1097/PAP.0b013e3181c66f4e. Adv Anat Pathol. 2010. PMID: 20032638 Review.
-
Retinoblastoma loss modulates DNA damage response favoring tumor progression.PLoS One. 2008;3(11):e3632. doi: 10.1371/journal.pone.0003632. Epub 2008 Nov 5. PLoS One. 2008. PMID: 18985151 Free PMC article.
Cited by
-
Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence.Nat Commun. 2024 Oct 24;15(1):9181. doi: 10.1038/s41467-024-52820-6. Nat Commun. 2024. PMID: 39448567 Free PMC article.
-
Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.Mol Cells. 2015 Aug;38(8):669-76. doi: 10.14348/molcells.2015.0175. Epub 2015 Jul 21. Mol Cells. 2015. PMID: 26194820 Free PMC article. Review.
-
Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells.Cell Stem Cell. 2021 Jun 3;28(6):1105-1124.e19. doi: 10.1016/j.stem.2021.03.005. Epub 2021 Apr 28. Cell Stem Cell. 2021. PMID: 33915078 Free PMC article.
-
Genome-wide profiles of H2AX and γ-H2AX differentiate endogenous and exogenous DNA damage hotspots in human cells.Nucleic Acids Res. 2012 Jul;40(13):5965-74. doi: 10.1093/nar/gks287. Epub 2012 Mar 29. Nucleic Acids Res. 2012. PMID: 22467212 Free PMC article.
-
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.Oncogene. 2016 Oct 13;35(41):5362-5376. doi: 10.1038/onc.2016.77. Epub 2016 Apr 4. Oncogene. 2016. PMID: 27041576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
